1. Overactive Bladder (OAB): What We Thought We Knew and What We Know Today 
William D Steers 
European Urology Supplements 
Volume 1, Issue 4, Pages 3-10 (July 2002)
DOI: /S (02)

2. Fig. 1
Prevalence of medical consultation and current medication in 1916 men and women aged 40–74 years with chronic bothersome OAB symptoms. Adapted with permission from [3].
European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )

3. Fig. 2
Role of the urothelium in OAB. Adapted with permission from [24]. VR: vanilloid; P: purinergic; NGF: nerve growth factor; trk-A: tyrosine kinase A; NO: nitric oxide; NK: neurokinin.
European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )

4. Fig. 3
Role of neuronal growth factor (NGF) in neural activity. Adapted with permission from [24].
European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )

5. Fig. 4
Percent of patients with depression in subgroups of patients with incontinence. Depression diagnosed by history and/or Beck Depression Inventory (BDI) scoring. Adapted with permission from [27].
European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )